New Drug Shows Encouraging Survival Results for Pancreatic Cancer

This post was originally published on this site

A clinical trial testing a new pancreatic cancer drug had promising initial results, say University of Michigan Rogel Cancer Center researchers in the Journal of Clinical Oncology. Investigators ran a phase 1 clinical trial that looked at AZD1775, an inhibitor …

Click here to read full article